|CrossRef Text and Data Mining|
|Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.|
|Surgical resection versus ablation for early hepatocellular carcinoma: The debate is still open|
|Bo Hyun Kim|
|Clin Mol Hepatol. 2022;28(2):174-176. Published online 2022 January 26 DOI: https://doi.org/10.3350/cmh.2021.0400|
Surgical resection versus ablation for early hepatocellular carcinoma: The debate is still open
Radiofrequency Ablation versus Surgical Resection as Primary Treatment of Hepatocellular Carcinoma Meeting the Milan Criteria: A Systematic Review
Is surgical resection still the treatment of choice for early hepatocellular carcinoma?
Radiofrequency ablation versus surgical resection for single nodule hepatocellular carcinoma: Long‐term outcomes
What is the optimal surgical treatment for hepatocellular carcinoma beyond the debate between anatomical versus non-anatomical resection?
Surgical resection versus radiofrequency ablation for the curative treatment of intrahepatic recurrent hepatocellular carcinoma: an unsolved question
Radiofrequency ablation versus surgical resection for intrahepatic hepatocellular carcinoma recurrence: a meta-analysis
Radiofrequency ablation versus resection for Barcelona clinic liver cancer very early/early stage hepatocellular carcinoma: a systematic review
323 Surgical Resection Versus Percutaneous Radiofrequency Ablation in Treatment of Hepatocellular Carcinoma: A Meta Analysis
FRI-476-Repeated surgical resection versus radiofrequency ablation for recurrent hepatocellular carcinoma after surgical resection : A propensity score matching analysis
|This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.|